Staining + Imaging + Analysis
GobLens Scan
Imaging Device
A high-performance anterior segment imaging system capable of high-magnification and deep-focus imaging, enabling precise visualization of microstructures, including goblet cells.
GobLens Drop
Fluorescent contrast agent
CELLSHINE has independently developed a novel fluorescent contrast agent specifically optimized for the imaging of goblet cells on the ocular surface. Designed with high biocompatibility and safety in mind, this agent enables selective visualization of goblet cells, contributing to the accurate diagnosis of conditions such as dry eye disease.
GobLens AI
An AI-powered analysis system that utilizes goblet cell imaging data to enable quantitative evaluation and diagnosis of ocular diseases such as dry eye.
Disease | Goblet Cell Changes by Disease | AI Quantitative Analysis Applications |
|---|---|---|
Dry Eye Disease (DED) | Decrease in goblet cells | Diagnosis, severity classification, treatment response Performance metrics: Sensitivity 93.2%, Specificity 91.5%, AUC 0.95 |
Sjögren’s Syndrome | Autoimmune-mediated loss | Differential diagnosis, prognosis prediction |
GVHD | Allogeneic immune response | Early diagnosis, immunosuppressant response evaluation |
OSD (Ocular Surface Disease) | Inflammatory damage | Differentiation of underlying cause, treatment decision |
Chemotherapy-Induced Toxicity | Toxicity/Inflammation | Adverse effect monitoring, drug management |
Disease
Dry Eye Disease (DED)
Goblet Cell Changes by Disease
Decrease in goblet cells
AI Quantitative Analysis Applications
Diagnosis, severity classification, treatment response
Performance metrics: Sensitivity 93.2%, Specificity 91.5%, AUC 0.95
Performance metrics: Sensitivity 93.2%, Specificity 91.5%, AUC 0.95
Disease
Sjögren’s Syndrome
Goblet Cell Changes by Disease
Autoimmune-mediated loss
AI Quantitative Analysis Applications
Differential diagnosis, prognosis prediction
Disease
GVHD
Goblet Cell Changes by Disease
Allogeneic immune response
AI Quantitative Analysis Applications
Early diagnosis, immunosuppressant response evaluation
Disease
OSD (Ocular Surface Disease)
Goblet Cell Changes by Disease
Inflammatory damage
AI Quantitative Analysis Applications
Differentiation of underlying cause, treatment decision
Disease
Chemotherapy-Induced Toxicity
Goblet Cell Changes by Disease
Toxicity/Inflammation
AI Quantitative Analysis Applications
Adverse effect monitoring, drug management